相关实验视频

Updated: Jun 27, 2025

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

目前和未来使用基于抗体的被动免疫来预防或控制HBV/HDV感染

Adam J Gehring¹, Loghman Salimzadeh²

¹Schwartz-Reisman Liver Research Centre, University Health Network, Toronto, ON, Canada; Department of Immunology, University of Toronto, Toronto, ON, Canada.

Antiviral research

|April 28, 2024

概括

针对乙型肝炎表面抗原的单克隆抗体为治疗慢性乙型肝炎和乙型肝炎提供了新的希望. 组合疗法对增强病毒清除和潜在治愈有希望.

科学领域:

肝病学肝病学是一种肝病学.
免疫学免疫学免疫学
病毒学病毒学

背景情况:

单克隆抗体疗法正在医学中获得吸引力.
人们对开发针对乙型肝炎表面抗原 (anti-HBs) 的抗体重新感兴趣,用于治疗慢性乙型肝炎 (HBV) 和乙型肝炎 (HDV).

研究的目的:

审查抗体在HBV感染保护和清除中的作用.
检查抗HBs抗体对HBV的保护性关联.
讨论抗体效应因子功能的必要性超出了HBV/HDV治愈的中和.

主要方法:

对现有研究和临床试验的文献综述.
在HBV/HDV感染中对抗体效应因子功能的分析.
来自被动抗体治疗试验的临床数据的评估.

主要成果:

抗体在保护和清除HBV感染方面发挥着至关重要的作用.
反HBs抗体与对HBV的保护有关.
除了中和之外的抗体效应器功能可能对治疗成功至关重要.

结论:

被动抗体疗法,特别是抗HBs单克隆抗体,是治疗HBV/HDV的一个有前途的策略.
涉及抗HBs抗体与新型抗HBV化合物和免疫调节药物的组合疗法是改善治疗结果和潜在治疗方法的有希望的途径.
在组合疗法中对被动抗体疗法的进一步临床研究是有必要的.

关键词:

抗HBss是什么意思慢性乙型肝炎慢性乙型肝炎甲型肝炎的三角形肝炎单克隆抗体是一种单克隆抗体.疫苗的疫苗效应

更多相关视频

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

相关概念视频

Active versus Passive Immunity

Active versus Passive Immunity

Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...

Humoral Immune Responses

Humoral Immune Responses